<DOC>
	<DOCNO>NCT01539876</DOCNO>
	<brief_summary>The purpose study assess fine needle aspiration methodology collect sufficient tumour cell measure tissue TNFa level serially human breast cancer sample receive Taxane treatment</brief_summary>
	<brief_title>Tumour Necrosis Factor Release Locally Advanced Breast Cancer Patients Receiving Neoadjuvant Docetaxel</brief_title>
	<detailed_description>This pilot study begin test clinical relevance TNFa pathway docetaxel response breast cancer patient receive Taxane chemotherapy . - Assess whether docetaxel induce TNFa expression breast cancer patient treat docetaxel</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Necrosis</mesh_term>
	<criteria>Biopsy proven LABC , Locally advance breast cancer . ( operable nonoperable ) Any T3/T4 N2 , N3 Clinical TNM stage breast cancer without metastasis ECOG Performance Status 0 , 1 2 . Patients able comprehend Letter Information capable give informed consent . Female age 18 year old History physical Negative serum pregnancy test woman child bear age Inflammatory cancer ( defined clinical evidence dermallymphatic tumour involvement . ) Ineligible chemotherapy Patients metastatic disease . Patients receive prior chemotherapy radiotherapy malignancy . Previous breast cancer diagnosis Pregnant lactating female ineligible . Female patient reproductive potential decline employ adequate contraceptive method ineligible . Participation concomitant trial .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>locally advanced breast cancer patient</keyword>
</DOC>